#United States #financial results #Envista Holdings #Brea #Spark Aligners

Envista Holdings Corporation Reports Strong Q3 2025 Results

Envista Holdings Corporation (NYSE: NVST) has announced robust financial results for the third quarter, which concluded on September 26, 2025. The company reported strong core sales growth across all major business sectors, reflecting strategic investments and innovative product launches.

Financial Performance Highlights

In this quarter, Envista reported sales of $670 million, marking a 9.4% increase from Q3 2024. Adjusted EBITDA reached $97 million—a significant 77% year-on-year rise—reflecting the effectiveness of the Envista Business System (EBS). Key financial metrics include:

• - GAAP Earnings Per Share (EPS): ($0.18)
• - Adjusted EPS: $0.32, representing a 167% increase compared to the previous year.
• - GAAP Net Loss: $30 million, mainly due to a tax charge associated with the restructuring of intercompany loans.

The overall adjusted EBITDA margin for the quarter stood at 14.5%, a substantial 540 basis points above the previous year, showcasing better cost management and operational efficiencies.

Positive Contributions from Major Businesses

Envista's growth trajectory was underscored by positive results from all major divisions, particularly in the specialty products and technologies segment. The company launched several new products that contributed to its revenue increase and captured market share with its innovative Spark aligners. Paul Keel, CEO of Envista, remarked on these achievements, stating, "This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations. We delivered growth across all major businesses and have returned to profitability within the Spark business segment. My thanks to our global teams for this progress."

Cash Flow and Share Repurchase

Envista's operating cash flow for this quarter was significant, at $79 million, with free cash flow amounting to $68 million, compared to $63 million in Q3 2024. During this period, the company was also active in share repurchases, buying back 2.1 million shares for roughly $41 million. By the end of the quarter, Envista had $108 million remaining in its stock repurchase program.

Updated Outlook for 2025

With these encouraging results, Envista is optimistic about the remainder of the fiscal year. The company has revised its guidance to reflect a core sales growth expectation of approximately 4%, along with an adjusted EBITDA margin of around 14%. Adjusted diluted EPS guidance is projected to be within $1.10 to $1.15, showing promising signs for sustained profitability.

Investment analysts will get a deeper look into this report as Envista plans to discuss its quarterly results on an investor conference call scheduled for October 30, 2025.

About Envista

Envista Holdings Corporation houses more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company’s mission revolves around facilitating improved patient care through industry-leading dental consumables, solutions, technologies, and services.

Envista operates with a strong emphasis on innovation and continuous improvement, aiming to meet the diverse needs of dental professionals globally. Its comprehensive portfolio addresses a wide array of dental challenges, proving Envista’s significant standing in a competitive industry.

For more information about Envista and its latest financial results and strategies, please visit Envista's official website.